Confusion and delirium

Cancer Neurology In Clinical Practice: Neurologic Complications of Cancer and Its Treatment: Second Edition

Volumn , Issue , 2008, Pages 65-90

  Caraceni, Augusto ^a   Bosisio, Marco ^a   Ingham, Jane M ^b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

cancer; confusion; delirium; encephalopathy; palliative care; psychosis

Indexed keywords

EID: 84891391641     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-59745-412-4_6     Document Type: Chapter

References (171)

1. Clouston PD, DeAngelis LM, Posner JB. The spectrum of neurologic disease in patients with systemic cancer. Ann Neurol 1992;31(3):268-273.
2. Lipowski ZJ. Delirium: Acute Confusional States. New York: Oxford University Press; 1990.
3. Jones W. Hippocates. English translation. London: William Heinemann; 1931.
4. Berrios GE. Delirium and confusion in the 19th century: a conceptual history. Br J Psychiatry 1981;139:439-449.
5. Steinberg D. What modern neuroscience can learn from Hughling Jackson. In: Clifford Rose F, ed. A Short History of Neurology. Oxford: Butter worth Heinemann; 1999:165-177.
6. Mesulam MM. Attention, confusional states and neglect. In: Mesulam MM, ed. Principles of Behavioral Neurology. Philadelphia: F.A.Davis; 1985:125-168.
7. Plum F, Posner JB. The Diagnosis of Stupor and Coma. Philadelphia: FA. Davis; 1980.
8. Adams R, Victor M. Principles of Neurology. 6th ed. New York: McGraw-Hill; 1997.
9. Engel GL, Romano J. Delirium, a syndrome of cerebral insufficiency. J Chronic Dis 1959;9(3):260-277.
10. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington DC: American Psychiatric Association; 2000:147.
11. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. revised. Washington DC: American Psychiatric Association; 1987.
12. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition. Washington DC: American Psychiatric Association; 1994.
13. World Health Organization. The ICD-10 classification of mental and behavioral disorders. Geneva: WHO Publications; 1992.
14. Ross CA. Etiological models and their phenomenological variants. CNS arousal systems: possible role in delirium. Int Psychogeriatr 1991;3(2):353-371.
15. Trzepacz PT. Update on the neuropathogenesis of delirium. Dement Geriatr Cogn Disord 1999;10:330-334.
16. Moruzzi G, Magoun HW. Brain stem reticular formation and activation of the EEG. Electroenceph Clin Neurophysiol 1949;1:455-473.
17. Moruzzi G, Magoun HW. Brain stem reticular formation and activation of the EEG. 1949. J Neuropsychiatry Clin Neurosci 1995;7(2):251-267.
18. Perry E, Walker M, Grace J, Perry R. Acetylcholine in mind: a neurotrasmitter correlate of consciousness. Trends Neurosci 1999;22(6):273-280.
19. Fukutani Y, Katsukawa K, Matsubara R et al. Delirium associated with Joseph disease. J Neurol Neurosurg Psychiatry 1993;56(11):1207-1212.
20. Mesulam MM, Waxman SG, Geschwind N et al. Acute confusional states with right middle cerebral artery infarctions. J Neurol Neurosurg Psychiatry 1976;39(1):84-89.
21. Baht R, Rockwood K. Delirium as a disorder of consciousness. J Neurol Neurosurg Psychiat 2007.
22. Folstein M, Folstein S, McHugh P. Mini-mental state. J Psychiatr Res 1975;12:189-198.
23. Fayers PM, Hjermstad MJ, Ranhoff AH et al. Which Mini-Mental State Exam items can be used to screen for delirium and cognitive impairment? J Pain Symptom Manage 2005;30(1):41-50.
24. Kaufer D, Catt K, Lopez O, De KS. Dementia with Lewy bodies: response of delirium-like features to donepezil. Neurology 1998;51(5):1512.
25. Blass JP, Gibson GE. Cerebrometabolic aspects of delirium in relationship to dementia. Dement Geriatr Cogn Disord 1999;10(5): 335-338.
26. Gibson GE, Blass JP, Huang HM et al. The cellular basis of delirium and its relevance to age-related disorders including Alzheimer's disease. Int Psychogeriatr 1991;3(2):373-395.
27. Stefano GB, Bilfinger TV, Fricchione GL. The immune neuro-link and the macrophage: postcardiotomy delirium, HIV associate dementia and psychiatry. Prog Neurobiol 1994;42(4):475-488.
28. Beloosesky Y, Hendel D, Weiss A et al. Cytokines and C-reactive protein production in hip-fracture-operated elderly patients. J Gerontol A Biol Sci Med Sci 2007;62(4):420-426.
29. Flacker JM, Lipsitz LA. Serum anticholinergic activity changes with acute illness in elderly medical patients. J Gerontol MS 1999;54A:M12-M6.
30. Barbato M, Rodriguez PJ. Thiamine deficiency in patients admitted to a palliative care unit. Pall Medicine 1994;8:320-324.
31. O'Keeffe, Tormey WP, Glasgow R et al. Thiamine deficiency in hospitalized elderly patients. Gronyology 1994;40(1):18-24.
32. Papersack T, Garbusinski J, Robberecht J et al. Clinical relevance of thiamine status amongst hospitalized elderly patients. Gerontology 1999;45:96-101.
33. Flacker JM, Lipsitz LA. Neural mechanisms of delirium: current hypotheses and evolving concepts. J Gerontol Biol Sci 1999;54A:B239-B46.
34. Rudolph JL, Jones RN, Grande LJ et al. Impaired executive function is associated with delirium after coronary artery bypass graft surgery. J Am Geriatr Soc 2006;54(6):937-941.
35. Trzepacz PT. The neuropathogenesis of delirium: a need to focus our research. Psychosomatics 1994;35:374-91.
36. Practice guideline for the treatment of patients with delirium. American Psychiatric Association. Am J Psychiatry 1999; 156(5 Suppl): 1-20.
37. Peterson JF, Pun BT, Dittus RS et al. Delirium and its motoric subtypes: a study of 614 critically ill patients. J Am Geriatr Soc 2006;54(3):479-484.
38. Ljubisavljevic V, Kelly B. Risk factors for development of delirium among oncology patients. Gen Hosp Psychiatry 2003;25(5): 345-352.
39. Minagawa H, Yosuke U, Yamawaki S, Ishitani K. Psychiatric morbidity in terminally ill cancer patients. Cancer 1996;78:1131-1137.
40. Lawlor PG, Gagnon B, Mancini IL et al. Occurrence, causes, and outcome of delirium in patients with advanced cancer. Arch Intern Med 2000;160:786-794.
41. Caraceni A, Nanni O, Maltoni M et al. Impact of delirium on the short-term prognosis of advanced cancer patients. Italian Multicenter Study Group on Palliative Care. Cancer 2000;89(5):1145-1149.
42. Gagnon P, Allard P, Masse B, DeSerres M. Delirium in terminal cancer: a prospective study using daily screening, early diagnosis and continuous monitoring. J Pain Symptom Manage 2000; 19(6):412-426.
43. Liptzin B, Levkoff SE, Cleary PD et al. An empirical study of diagnostic criteria for delirium. Am J Psychiatry 1991;148(4):454-457.
44. Lewis LM, Miller DK, Morley JE, et al. Unrecognized delirium in ED geriatric patients. Am J Emerg Med 1995;13(2):142-145.
45. Caraceni A, Grassi L. Delirium: Acute Confusional States in Palliative Medicine. Oxford: Oxford University Press; 2003.
46. Wolf HG, Curran D. Nature of delirium and allied states: the disergastic reaction. Arch Neurol Psychiatry 1935;33:1175-1215.
47. Liptzin B, Levkoff SE. An empyrical study of delirium subtypes. Br J Psychiatry 1992;161:843-845.
48. Spiller JA, Keen JC. Hypoactive delirium: assessing the extent of the problem for inpatient specialist palliative care. Palliat Med 2006;20(1):17-23.
49. Pandharipande P, Cotton BA, Shintani A et al. Motoric subtypes of delirium in mechanically ventilated surgical and trauma intensive care unit patients. Intensive Care Med 2007;online.
50. Breitbart W, Gibson C, Tremblay A. The delirium experience: delirium recall and delirium-related distress in hospitalized patients with cancer, their spouses/caregivers, and their nurses. Psychosomatics 2002;43(3): 183-194.
51. Chedru F, Geschwind N. Writing disturbances in acute confusional state. Neuropsychologia 1972;10:343-353.
52. Macleod AD, Whitehead LE. Dysgraphia in terminal delirium. Palliat Med 1997;11:127-132.
53. th ed. Washington, DC: American Psychiatric Association; 2000.
54. Pisani F, Oteri G, Costa C et al. Effects of psychotropic drugs on seizure threshold. Drug Saf 2002;25(2):91-110.
55. Taylor MA, Fink M. Catatonia in psychiatric classification: a home of its own. Am J Psychiatry 2003;160(7):1233-1241.
56. Inouye SK, van Dyck CH, Alessi CA et al. Clarifying confusion: the confusion assessment method-a new method for detection of delirium. Ann Intern Med 1990;113(12):941-948.
57. Zou Y, Cole M, Primeau F et al. Detection and diagnosis of delirium in the elderly: psychiatrist diagnosis, confusion assessment method, or consensus diagnosis? Int Psychogeriatr 1998;10(3): 303-308.
58. Trzepacz PT, Baker RW, Greenhouse J. A symptom rating scale for delirium. Psychiatry Res 1988;23(1):89-97.
59. Breitbart W, Rosenfeld B, Roth A et al. The memorial delirium assessment scale. J Pain Symptom Manage 1997;13(3):128-137.
60. Smith MJ, Breitbart WS, Piatt MM. A critique of instruments and methods to detect, diagnose, and rate delirium. J Pain Symptom Manage 1994;10:35-77.
61. Hjermstad M, Loge JH, Kaasa S. Methods for assessment of cognitive failure and delirium in palliative care patients: implications for practice and research. Palliat Med 2004;18(6):494-506.
62. Gaudreau JD, Gagnon P, Harel F et al. Impact on delirium detection of using a sensitive instrument integrated into clinical practice. Gen Hosp Psychiatry 2005;27(3): 194-199.
63. Pompei P, Foreman M, Cassel C et al. Detecting delirium among hospitalized older patients. Arch Intern Med 1995;155:301-307.
64. Rockwood K, Gooodman J, Flynn M et al. Cross-validation of the delirium rating scale in older patients. J Am Geriatr Soc 1996;44:839-842.
65. Grassi L, Caraceni A, Beltrami E et al. Assessing delirium in cancer patients: the Italian versions of the delirium rating scale and the memorial delirium assessment scale. J Pain Symptom Manage 2001;21(1):59-68.
66. Trzepacz PT, Mittal D, Torres R et al. Validation of the delirium rating scale-revised-98: comparison with the delirium rating scale and the cognitive test for delirium. J Neuropsychiatry Clin Neurosci 2001;13(2):229-242.
67. Trzepacz PT, Brenner RP, Coffman GC et al. Delirium in liver transplantation candidates: discriminant analysis of multiple test variables. Biol Psychiatry 1988;24:3-15.
68. Jacobson SA, Leuchter AF, Walter DO. Conventional and quantitative EEG in the diagnosis of delirium among the elderly. J Neurol Neurosurg Psychiatry 1993;56:153-158.
69. Jacobson S, Jerrier H. EEG in delirium. Semin Clin Neuropsychiatry 2000;5(2):86-92.
70. Young GB, McLachlan RS, Kreeft JH et al. An electroencephalographic classification system for coma. Can J Neurol Sci 1997;24: 329-325.
71. Wengs WJ, Talwar D, Bernard J. Ifosfamide-induced nonconvulsive status epilepticus. Arch Neurol 1993;50:1104-1105.
72. Schmidley JW, Messing RO. Agitated confusional states in patients with right hemisphere infarctions. Stroke 1984;5:883-885.
73. Mori E, Yamadori A. Acute confusional state and acute agitated delirium: occurrence after infarction in the right middle cerebral artery territory. Arch Neurol 1987;44:1139-1143.
74. Henon H, Lebert F, Durieu I et al. Confusional state in stroke: relation to preexisting dementia, patient characteristics, and outcome. Stroke 1999;30:773-779.
75. Wasserstrom WR, Glass JP, Posner JB. Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer 1982;49(4):759-772.
76. Posner JB. Neurologic Complications of Cancer. Philadelphia: FA. Davis; 1995.
77. Formaglio F, Caraceni A. Meningeal metastases: clinical aspects and diagnosis. Ital J Neurol Sci 1998;19(3):133-149.
78. Weitzener MA, Olofson SM, Forman AD. Patients with malignant meningitis presenting with neuropsychiatric manifestations. Cancer 1995;76:1804-1808.
79. Grossman SA, Trump DL, Chen DC et al. Cerebrospinal fluid flow abnormalities in patients with neoplastic meningitis: an evaluation using lllindium-DTPA ventriculography. Am J Med 1982;73(5):641-647.
80. Trzepacz P, Ho V, Mallavarapu H. Cholinergic delirium and neurotoxicity associated with tacrine for Alzheimer's dementia. Psycho-somatics 1996;37(3):299-301.
81. Bruera E, Macmillan K, Hanson J et al. The cognitive effects of the administration of narcotic analgesics in patients with cancer pain. Pain 1989;39(1):13-16.
82. Zacny J. A review of the effects of opioids on psychomotor function and cognitive functioning in humans. Exp Clin Psychopharmacol 1995;3(4):432-466.
83. Sjogren P, Olsen AK, Thomsen AB et al. Neuropsychological performance in cancer patients: the role of oral opioids, pain, and performance status. Pain 2000;86(3):237-245.
84. Tuma R, DeAngelis LM. Altered mental status in patients with cancer. Arch Neurol 2000;57(12):1727-1731.
85. Gaudreau JD, Gagnon P, Roy MA et al. Opioid medications and longitudinal risk of delirium in hospitalized cancer patients. Cancer 2007; 109(11):2365-2673.
86. Jellema JG. Hallucination during sustained-release morphine and methadone administration. Lancet 1987;2(8555):392.
87. Caraceni A, Martini C, De Conno F et al. Organic brain syndromes and opioid administration for cancer pain. J Pain Symptom Manage 1994;9(8):527-533.
88. Hagen N, Swanson R. Strychnine-like multifocal myoclonus and seizures in extremely high-dose opioid administration: treatment strategies. J Pain Symptom Manage 1997;14:51-58.
89. Sjogren P, Jonsson T, Jensen NH et al. Hyperalgesia and myoclonus in terminal cancer patients treated with continuous intravenous morphine. Pain 1993;55(1):93-97.
90. Gaudreau JD, Gagnon P, Harel F et al. Psychoactive medications and risk of delirium in hospitalized cancer patients. J Clin Oncol 2005;23(27):6712-6718.
91. Francis J, Kapoor WN. Prognosis after hospital discharge of older medical patients with delirium. J Am Geriatr Soc 1992;40:601-606.
92. Schor JD, Levkoff SE, Lipsitz LA et al. Risk factors for delirium in hospitalized elderly. JAMA 1992;267(6):827-831.
93. Inouye SK, Viscoli CM, Horwitz RI et al. A predictive model for delirium in hospitalized elderly medical patients based on admission characteristics. Ann Intern Med 1993;119(6):474-481.
94. Ferguson JA, Suelzer CJ, Eckert GJ et al. Risk factors for delirium tremens development. J Gen Intern Med 1996;11(7):410-414.
95. Inouye SK, Charpentier PA. Precipitating factors for delirium in hospitalized elderly persons: predictive model and interrelationship with baseline vulnerability. JAMA 1996;275(11):852-857.
96. Inouye SK, Bogardus ST, Charpentier PA et al. A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 1999;340(9):669-676.
97. Turner RC, Lichstein PR, Peden JG, Jr. et al. Alcohol withdrawal syndromes: a review of pathophysiology, clinical presentation, and treatment. J Gen Intern Med 1989;4(5):432-444.
98. van Munster BC, Korevaar JC, de Rooij SE et al. Genetic polymorphisms related to delirium tremens: a systematic review. Alcohol Clin Exp Res 2007;31(2):177-184.
99. Seibert CP. Recognition, management, and prevention of neuropsychological dysfunction after operation. Int Anesthesiol Clin 1986;24(4):39-58.
100. Smith LW, Dimsdale JE. Postcardiotomy delirium: conclusions after 25 years? Am J Psychiatry 1989;146(4):452-458.
101. Berggren D, Gustafson Y, Eriksson B et al. Postoperative confusion after anesthesia in elderly patients with femoral neck fractures. Anesth Analg 1987;66(6):497-504.
102. Marcantonio ER, Goldman L, Mangione CM et al. A clinical prediction rule for delirium after elective noncardiac surgery. JAMA 1994;271(2):134-139.
103. O'Keeffe ST, Chonchubhair A. Postoperative delirium in the elderly. Br J Anaesth 1995;73(5):673-687.
104. Marcantonio ER, Juarez G, Goldman L et al. The relationship of postoperative delirium with psychoactive medications. JAMA 1994;272(19):1518- 1522.
105. Marcantonio ER, Goldman L, Orav EJ et al. The association of intraoperative factors with the development of postoperative delirium. Am J Med 1998;105(5):380-384.
106. O'Keeffe ST. Clinical subtypes of delirium in the elderly. Dement Geriatr Cogn Disord 1999;10:380-385.
107. Carlson LA, Gottfries CG, Winbland B et al. (eds.). Delirium in the elderly: epidemiological, pathogenetic, and treatment aspects. Dement Geriatr Cog Disord 1999;10(5):306-129.
108. Farrell KR, Ganzini L. Misdiagnosing delirium as depression in medically ill elderly patients. Arch Intern Med 1995;155:2459-2464.
109. Morita T, Tsunoda J, Inoue S et al. The palliative prognostic index: a scoring system for survival prediction of terminally ill cancer patients. Support Care Cancer 1999;7(3):128-133.
110. Casarett DJ, Inouye SK. Diagnosis and management of delirium near the end of life. Ann Intern Med 2001;135(1):32-40.
111. Ripamonti C, Bruera E. CNS adverse effects of opioids in cancer patients: guidelines for treatment. CNS Drugs 1997;8(1):21-37.
112. Guideline Watch: Practice guideline for the treatment of patients with delirium. 2006.
113. Inouye SK, Bogardus ST, Jr., Williams CS et al. The role of adherence on the effectiveness of nonpharmacologic interventions: evidence from the delirium prevention trial. Arch Intern Med 2003;163(8):958-964.
114. Borreani C, Caraceni A, Tamburini M. Counselling for the confused patient and the family. In: Portenoy RK, Bruera E, eds. Topics in Palliative Care; 1997:45-54.
115. Centeno C, Sanz A, Bruera E. Delirium in advanced cancer patients. Palliat Med 2004;18(3):184-194.
116. Morita T, Hirai K, Sakaguchi Y et al. Family-perceived distress from delirium-related symptoms of terminally ill cancer patients. Psychosomatics 2004;45(2):107-113.
117. Bruera E, Fainsinger RL, Miller MJ et al. The assessment of pain intensity in patients with cognitive failure: a preliminary report. J Pain Symptom Manage 1992;7(5):267-270.
118. Coyle N, Breitbart W, Weaver S et al. Delirium as a contributing factor to "crescendo" pain: three case reports. J Pain Symptom Manage 1994;9(1):44-17.
119. British Geriatrics Society and Royal College of Physicians. Guidelines for the prevention, diagnosis, and management of delirium in older people: concise guidance to good practice series. No 6. London: Royal College of Physicians; 2006.
120. Breitbart W, Marotta R, Piatt MM et al. A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry 1996;153(2):231-237.
121. Wirshing WC. Movement disorders associated with neuroleptic treatment. J Clin Psychiatry 2001;62 Suppl 21:15-18.
122. Strawn JR, Keck PE, Jr., Caroff SN. Neuroleptic malignant syndrome. Am J Psychiatry 2007;164(6):870-876.
123. Wilt JL, Minnema AM, Johnson RF et al. Torsade de pointes associated with the use of intravenous haloperidol. Ann Intern Med 1993;119(5):391-1.
124. Hunt N, Stern TA. The association between intravenous haloperidol and torsades de pointes. Psychosomatics 1995;36(6):541-9.
125. DiSalvo TG, O'Gara PT. Torsade de pointes caused by high-dose intravenous halpoeridol in cardiac patients. Clin Cardiol 1995;18(5):285-290.
126. Jackson T, Ditmanson L, Phibbs B. Torsade de pointes and low-dose oral haloperidol. Arch Intern Med 1997;157(17):2013-2015.
127. Tei Y, Morita T, Inoue S et al. Torsades de pointes caused by a small dose of risperidone in a terminally ill cancer patient. Psychosomatics 2004;45(5):450-451.
128. Stollberger C, Huber JO, Finsterer J. Antipsychotic drugs and QT prolongation. Int Clin Psychopharmacol 2005;20(5): 243-251.
129. Justo D, Prokhorov V, Heller K et al. Torsade de pointes induced by psychotropic drugs and the prevalence of its risk factors. Acta Psychiatr Scand 2005;111(3):81-86.
130. Zeltser D, Justo D, Halkin A et al. Torsade de pointes due to noncardiac drugs: most patients have easily identifiable risk factors. Medicine (Baltimore) 2003;82(4):282-290.
131. Liptzin B. Delirium. In: Sadavoy J, Lazarus L, Jarvik L et al. (eds.). Comprehensive Review of Geriatric Psychiatry. 2nd ed. Washington, DC: American Psychiatric Press; 1996:479-495.
132. Shapiro BA, Warren J, Egol AB et al. Practice parameters for intravenous analgesia and sedation for adult patients in the intensive care unit: an executive summary. Society of Critical Care Medicine. Crit Care Med 1995;23(9):1596-1600.
133. Tesar GE, Murray GB, Cassem NH. Use of high-dose intravenous haloperidol in the treatment of agitated cardiac patients. J Clin Psychopharmacol 1985;5(6):344-347.
134. Riker RR, Fraser GL, Cox PM. Continuous infusion of haloperidol controls agitation in critically ill patients. Crit Care Med 1994;22(3):433-440.
135. Levenson JL. High-dose intravenous haloperidol for agitated delirium following lung transplantation. Psychosomatics 1995;36(1): 66-68.
136. Lonergan E, Britton AM, Luxenberg J et al. Antipsychotics for delirium. Cochrane Database Syst Rev 2007(2):CD005594.
137. Riker RR, Fraser GL. Adverse events associated with sedatives, analgesics, and other drugs that provide patient comfort in the intensive care unit. Pharmacotherapy 2005;25(5 Pt 2):8S-18S.
138. O'Brien JM, Rockwood RP, Suh KI. Haloperidol-induced torsade de pointes. Ann Pharmacother 1999;33(10): 1046-1050.
139. Riker RR, Fraser GL, Richen P. Movement disorders associated with withdrawal from high-dose intravenous haloperidol therapy in delirious ICU patients. Chest 1997;111(6):1778-1781.
140. Di Salvo TG, O'Gara PT. Torsade de pointes caused by high-dose intravenous haloperidol in cardiac patients. Clin Cardiol 1995;18(5):285-290.
141. Thomas H, Schwartz E, Petrilli R. Droperidol versus haloperidol for chemical restraint of agitated and combative patients. Ann Emerg Med 1992;21:407-413.
142. Frye MA, Coudreaut MF, Hakeman SM et al. Continuous droperidol infusion for management of agitated delirium in an intensive care unit. Psychosomatics 1995;36(3):301-305.
143. Sipahimalani A, Masand P. Use of risperidone in delirium: case reports. Ann Clin Psychiatry 1997;9(2):105-107.
144. Breitbart W, Tremblay A, Gibson C. An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients. Psychosomatics 2002;43(3)-.n5-lS2.
145. Boettger S, Breitbart W. Atypical antipsychotics in the management of delirium: a review of the empirical literature. Palliat Support Care 2005;3(3):227-237.
146. Lacasse H, Perreault MM, Williamson DR. Systematic review of antipsychotics for the treatment of hospital-associated delirium in medically or surgically ill patients. Ann Pharmacother 2006;40(11):1966-1973.
147. Mayo-Smith MF, Beecher LH, Fischer TL et al. Management of alcohol withdrawal delirium: an evidence-based practice guideline. Arch Intern Med 2004;164(13):1405-1412.
148. Stanley KM, Worrall CL, Lunsford SL et al. Experience with an adult alcohol withdrawal syndrome practice guideline in internal medicine patients. Pharmacotherapy 2005;25(8):1073-1083.
149. Arcangeli A, Antonelli M, Mignani V et al. Sedation in PACU: the role of benzodiazepines. Curr Drug Targets 2005;6(7):745-748.
150. Bottomley DM, Hanks GW. Subcutaneous midazolam infusion in palliative care. J Pain Symptom Manage 1990;5(4):259-261.
151. Burke AL, Diamond PL, Hulbert J et al. Terminal restlessness: its management and the role of midazolam. Med J Aust 1991;155(7): 485-187.
152. Stiefel F, Fainsinger R, Bruera E. Acute confusional states in patients with advanced cancer. J Pain Symptom Manage 1992;7(2):94-98.
153. Burke AL. Palliative care: an update on "terminal restlessness. Med J Aust 1997;166:39-42.
154. Morita T, Tei Y, Inoue S. Correlation of the dose of midazolam for symptom control with administration periods: the possibility of tolerance. J Pain Symptom Manage 2003;25(4):369-375.
155. Fernandez F, Levy JK, Mansell PW. Management of delirium in terminally ill AIDS patients. Int J Psychiatry Med 1989; 19(2): 165-172.
156. Fernandez F, Adams F, Levy JK et al. Cognitive impairment due to AIDS-related complex and its response to psychostimulants. Psychosomatics 1988;29(1):38-16.
157. Arbour RB. Propylene glycol toxicity related to high-dose lorazepam infusion: case report and discussion. Am J Crit Care 1999;8(1):499-506.
158. Cawley MJ. Short-term lorazepam infusion and concern for propylene glycol toxicity: case report and review. Pharmacotherapy 2001;21(9):1140-1144.
159. Parker MG, Fraser GL, Watson DM et al. Removal of propylene glycol and correction of increased osmolar gap by hemodialysis in a patient on high-dose lorazepam infusion therapy. Intensive Care Med 2002;28(1):81-84.
160. Mullins ME, Barnes BJ. Hyperosmolar metabolic acidosis and intravenous Lorazepam. N Engl J Med 2002;347(11):857-858; author reply-8.
161. Slatkin NE, Rhiner M, Bolton TM. Donepezil in the treatment of opioid-induced sedation: report of six cases. J Pain Symptom Manage 2001;21(5):425-438.
162. Levenson JA. Should psychostimulants be used to treat delirious patients with depressed mood. J Clin Psychiatry 1992;53(2):69.
163. Morita T, Otani H, Tsunoda J et al. Succesful palliation of hypoactive delirium due to multiorgan failure by oral methylphenidate. Supp Care Cancer 2000;8(2):134-137.
164. Gagnon B, Low G, Schreier G. Methylphenidate hydrochloride improves cognitive function in patients with advanced cancer and hypoactive delirium: a prospective clinical study. J Psychiatry Neurosci 2005;30(2): 100-107.
165. Burns MJ, Linden CH, Graudins A, Brown RM, Fletcher KE. A comparison of physostigmine and benzodiazepines for the treatment of anticholinergic poisoning. Ann Emerg Med 2000;35(4):374-381.
166. Kalisvaart KJ, de Jonghe JF, Bogaards MJ et al. Haloperidol prophylaxis for elderly hip-surgery patients at risk for delirium: a randomized placebo-controlled study. J Am Geriatr Soc 2005;53(10): 1658-1666.
167. Siddiqi N, Stockdale R, Britton AM et al. Interventions for preventing delirium in hospitalised patients. Cochrane Database Syst Rev 2007(2):CD005563.
168. Koponen HJ, Riekkinen PJ. A prospective study of delirium in elderly patients admitted to a psychiatric hospital. Psychol Med 1993;23:103-109.
169. Levkoff SE, Evans DA, Liptzin B et al. Delirium: the occurrence and persistence of symptoms among elderly hospitalized patients. Arch Intern Med 1992;152(2):334-340.
170. van Hemert AM, van der Mast RC, Hengeveld MW et al. Excess mortality in general hospital patients with delirium: a 5-year follow-up of 519 patients seen in psychiatric consultation. J Psychosom Res 1994;38(4):339-346.
171. Leslie DL, Zhang Y, Holford TR et al. Premature death associated with delirium at 1-year follow-up. Arch Intern Med 2005;165(14):1657-1662.